应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
BMY 施贵宝
盘前交易 12-23 08:41:11 EST
54.66
+0.47
+0.87%
盘前
54.63
-0.03
-0.05%
08:39 EST
最高
54.82
最低
54.04
成交量
2,515万
今开
54.14
昨收
54.19
日振幅
1.43%
总市值
1,113亿
流通市值
1,110亿
总股本
20.36亿
成交额
13.70亿
换手率
1.24%
流通股本
20.32亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
2025生物制药5大失败临床试验
医药魔方 · 10:10
2025生物制药5大失败临床试验
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
智通财经 · 12-20
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
施贵宝表示其对战略储备的捐赠将包括畅销抗凝药物Eliquis
美股速递 · 12-20
施贵宝表示其对战略储备的捐赠将包括畅销抗凝药物Eliquis
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
美股速递 · 12-20
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
公司将通过Trumprx网站以更低价格直接向消费者提供多种药物-美国官员
美股速递 · 12-20
公司将通过Trumprx网站以更低价格直接向消费者提供多种药物-美国官员
多家制造商同意向美国战略储备捐赠活性药物成分
美股速递 · 12-20
多家制造商同意向美国战略储备捐赠活性药物成分
港股异动 | 和铂医药-B(02142)早盘涨超8% 公司与百时美施贵宝签订超10亿美元BD交易
智通财经 · 12-19
港股异动 | 和铂医药-B(02142)早盘涨超8% 公司与百时美施贵宝签订超10亿美元BD交易
施贵宝加拿大欢迎CDA对Opdivo®与Yervoy®联合用于MSI-H/DMMR转移性结直肠癌的一线治疗的积极推荐
美股速递 · 12-17
施贵宝加拿大欢迎CDA对Opdivo®与Yervoy®联合用于MSI-H/DMMR转移性结直肠癌的一线治疗的积极推荐
港股异动 | 和铂医药-B(02142)仍跌2% 与百时美施贵宝达成全球战略合作 潜在收益超10亿美元
智通财经 · 12-17
港股异动 | 和铂医药-B(02142)仍跌2% 与百时美施贵宝达成全球战略合作 潜在收益超10亿美元
和铂医药-B与施贵宝达成全球战略合作与许可协议
投资观察 · 12-17
和铂医药-B与施贵宝达成全球战略合作与许可协议
美银上调施贵宝目标价至61美元
格隆汇 · 12-16
美银上调施贵宝目标价至61美元
施贵宝：Bofa全球研究将评级从中性上调至买入；目标价由52美元上调至61美元
美股速递 · 12-15
施贵宝：Bofa全球研究将评级从中性上调至买入；目标价由52美元上调至61美元
2025年平均回报近28%！2026年《巴伦》选股：亚马逊及另外9只股值得买入
老虎资讯综合 · 12-15
2025年平均回报近28%！2026年《巴伦》选股：亚马逊及另外9只股值得买入
产业新闻 | FDA授予百时美施贵宝PD-1疗法组合优先审评资格；创新帕金森病免疫疗法积极试验结果公布
药明康德 · 12-12
产业新闻 | FDA授予百时美施贵宝PD-1疗法组合优先审评资格；创新帕金森病免疫疗法积极试验结果公布
美国食品药品监督管理局（FDA）对施贵宝Opdivo®（Nivolumab）联合化疗治疗经典型霍奇金淋巴瘤的申请给予优先审评
美股速递 · 12-11
美国食品药品监督管理局（FDA）对施贵宝Opdivo®（Nivolumab）联合化疗治疗经典型霍奇金淋巴瘤的申请给予优先审评
富国银行上调施贵宝目标价至55美元
中金财经 · 12-11
富国银行上调施贵宝目标价至55美元
Biontech与施贵宝公布Pumitamig全球二期研究数据
投资观察 · 12-09
Biontech与施贵宝公布Pumitamig全球二期研究数据
BioNTech Se：Pumitamig联合化疗在所有四种化疗方案中的安全性均可控
美股速递 · 12-09
BioNTech Se：Pumitamig联合化疗在所有四种化疗方案中的安全性均可控
美股异动 | 百时美施贵宝(BMY.US)涨5% 公司将继续阿尔茨海默病研究
智通财经 · 12-03
美股异动 | 百时美施贵宝(BMY.US)涨5% 公司将继续阿尔茨海默病研究
施贵宝股价在盘前上涨3.4%，继续招募阿尔茨海默病药物试验患者
美股速递 · 12-03
施贵宝股价在盘前上涨3.4%，继续招募阿尔茨海默病药物试验患者
加载更多
公司概况
公司名称：
施贵宝
所属市场：
NYSE
上市日期：
--
主营业务：
百时美施贵宝公司于1933年8月根据特拉华州法律注册成立，名为百时美公司，继承了1887年在纽约成立的一家企业。1989年，由于合并，公司更名为百时美施贵宝公司。该公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。该公司预计，对Celgene和MyoKardia的收购将进一步将公司定位为领先的生物制药公司，通过几项近期资产和额外的外部合作伙伴关系扩大其肿瘤学、血液学、免疫学和心血管领域的投资组合。
发行价格：
--
{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":54.66,"timestamp":1766437200000,"preClose":54.19,"halted":0,"volume":25146303,"hourTrading":{"tag":"盘前","latestPrice":54.63,"preClose":54.66,"latestTime":"08:39 EST","volume":1832,"amount":100221.28940800001,"timestamp":1766497154762},"delay":0,"floatShares":2031646263,"shares":2035753027,"eps":2.970486,"marketStatus":"盘前交易","change":0.47,"latestTime":"12-23 08:41:11 EST","open":54.14,"high":54.815,"low":54.0375,"amount":1369927587.2618701,"amplitude":0.014348,"askPrice":55,"askSize":521,"bidPrice":54.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":2.970486,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766500200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":54.66,"dividendRate":0.045406,"preHourTrading":{"tag":"盘前","latestPrice":54.63,"preClose":54.66,"latestTime":"08:39 EST","volume":1832,"amount":100221.28940800001,"timestamp":1766497154762},"postHourTrading":{"tag":"盘后","latestPrice":54.74,"preClose":54.66,"latestTime":"19:51 EST","volume":9516550,"amount":520174696.584801,"timestamp":1766451104724},"volumeRatio":1.1159661914608001,"impliedVol":0.2506,"impliedVolPercentile":0.0321},"requestUrl":"/m/hq/s/BMY","defaultTab":"news","newsList":[{"id":"2593469996","title":"2025生物制药5大失败临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2593469996","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593469996?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:10","pubTimestamp":1766455833,"startTime":"0","endTime":"0","summary":"Biospace近日总结了生物制药领域在2025年五项代价高昂的临床失败，并分析了其引发的连锁反应。Alector与GSK于2021年7月达成合作，GSK投入预付款7亿美元，并承诺最高15亿美元的里程碑付款，以合作研发两款神经领域药物。双方2021年协议中的第二款药物nivisnebart目前处于II期研发阶段，用于治疗早期阿尔茨海默病。▌诺和诺德GLP-1药物阿尔茨海默适应症临床试验失利在神经科学领域折戟的还有诺和诺德。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223102629a46cc8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223102629a46cc8bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","LU1894683264.USD","PFE","BK4533","BK4213","BK4588","LU0456855351.SGD","LU1057294990.SGD","SGXZ57979304.SGD","LU1023059063.AUD","LU1093756168.USD","SG9999002224.SGD","IE000M9KFDE8.USD","LU0170899867.USD","LU1829250122.USD","IE00BKVL7J92.USD","BK4585","BK4581","LU0306806265.USD","LU1066053197.SGD","SG9999011175.SGD","BK4550","IE00BLSP4452.SGD","BK4599","LU0321505868.SGD","BK4592","ALEC","IE00B19Z3B42.SGD","LU1894683348.USD","SG9999013999.USD","LU0122379950.USD","SG9999002232.USD","LU1093756325.SGD","BMY","LU1883839398.USD","GSK.UK","LU0058720904.USD","LU0321505439.SGD","LU0234572021.USD","LU0306807586.USD","NVO","LU0225771236.USD","IE00BLSP4239.USD","LU0225284248.USD","SG9999001176.USD","BK4534","IE00B19Z3581.USD","LU0985481810.HKD","IE0002270589.USD","GSK","IE00BBT3K403.USD","BK4568","BK4139","BK4007","SG9999003800.SGD","IE00BZ1G4Q59.USD","LU0154236417.USD","LU0868494617.USD","LU0289739699.SGD","LU1066051498.USD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际，多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持。在此次协议中，最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示，今年7月他致信要求降价的17家大型制药企业中，已有14家同意大幅下调药价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2106854487.HKD","LU1116320737.USD","SG9999015341.SGD","BK4007","BK4588","IE00BLSP4239.USD","LU1093756325.SGD","LU0648001328.SGD","LU0211331839.USD","GILD","LU1941712264.USD","LU1057294990.SGD","IE00BBT3K403.USD","SG9999014575.USD","LU1201861249.SGD","IE0009355771.USD","LU1571399168.USD","LU2023250504.SGD","LU2089984988.USD","LU1035773651.USD","LU1061106388.HKD","LU2468319806.SGD","LU0267386448.USD","LU1023059063.AUD","LU0985320562.USD","IE00B1BXHZ80.USD","LU0098860793.USD","LU2361044865.SGD","LU0289739699.SGD","LU0861579265.USD","LU1989772923.USD","LU2361044949.HKD","LU0096364046.USD","LU1430594728.SGD","BK4532","BMY","AMGN","LU2360032135.SGD","IE00BJT1NW94.SGD","JNJ","LU1093756168.USD","LU0265550359.USD","LU0985481810.HKD","LU1868836914.USD","LU1868836757.USD","SG9999001176.USD","LU0130517989.USD","IE000M9KFDE8.USD","LU0114720955.EUR","IE00BN8TJ469.HKD","LU2324357040.USD","LU2461242641.AUD","LU0265550946.USD","NVS","ABBV","LU1670711040.USD","LU0203347892.USD","LU2125154935.USD","IE00BLSP4452.SGD","LU0456855351.SGD","REGN","LU0203345920.USD","LU2125154778.USD","SG9999002232.USD","LU1868837300.USD","IE00B2B36J28.USD","SG9999014559.SGD","LU1066053197.SGD","BK4533","LU1032466523.USD","SNY","LU1699723380.USD","LU2361045086.USD","LU0965508806.USD","LU0321505439.SGD","LU1670711123.USD","SG9999002224.SGD","BK4550","LU0130102774.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU1323610961.USD","LU1983299246.USD","BK4581","LU0882574055.USD","LU1069347547.HKD","GSK","LU0965509010.AUD","LU0225771236.USD","LU1291159041.SGD","SG9999001176.SGD","SG9999013999.USD","LU0070302665.USD","LU0238689110.USD","SGXZ57979304.SGD","LU1261432733.SGD","LU1934455863.HKD","IE00BJJMRZ35.SGD","LU0237698245.USD","LU0058720904.USD","BK4585","LU0122379950.USD","LU0306806265.USD","LU1929549753.HKD","LU0965509101.SGD","LU0208291251.USD","LU0106261372.USD","SG9999014542.SGD","LU1941712348.USD","LU2242646821.SGD","LU1670710588.SGD","LU1868836591.USD","LU1974910355.USD","BK4559","LU2023250843.SGD","LU1162221912.USD","LU2112291526.USD","LU0225284248.USD","IE00BFXG1179.USD","SG9999001440.SGD","IE0002141913.USD","LU0234572021.USD","LU0306807586.USD","LU1066051498.USD","LU1934455277.USD","LU1116320901.HKD","LU1917777945.USD","LU1989772840.SGD","LU1868837136.USD","LU0965509283.SGD","BK4516","LU2242652126.USD","AZN","LU0061475181.USD","LU1037948897.HKD","LU1074936037.SGD","LU1037948541.HKD","LU1585245621.USD","SG9999015358.SGD","BK4534","LU0320765646.SGD","SG9999014567.USD","LU0006306889.USD","LU0477156953.USD","LU1989771016.USD","LU1670710661.SGD","LU0320765489.SGD","LU1718418525.SGD","MRK","LU1934455194.USD","04332","LU0980610538.SGD","LU1066051811.HKD","ROG","IE00B4R5TH58.HKD","LU0266013472.USD","LU1066051225.USD","LU0868494617.USD","LU0321505868.SGD","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"1162651371","title":"施贵宝表示其对战略储备的捐赠将包括畅销抗凝药物Eliquis","url":"https://stock-news.laohu8.com/highlight/detail?id=1162651371","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162651371?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:55","pubTimestamp":1766174153,"startTime":"0","endTime":"0","summary":"施贵宝表示其对战略储备的捐赠将包括畅销抗凝药物Eliquis","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4581","LU0211331839.USD","LU0225771236.USD","LU1202635105.USD","LU1261432733.SGD","IE00BBT3K403.USD","LU1974910355.USD","LU1983299246.USD","LU1670756490.USD","BK4550","LU2133065610.SGD","LU1645745479.HKD","IE00B1BXHZ80.USD","LU0098860793.USD","LU1718418525.SGD","SGXZ57979304.SGD","LU0648001328.SGD","LU1674673691.USD","LU0965509101.SGD","LU1941712348.USD","LU1481600234.SGD","LU2324357040.USD","LU1934455277.USD","LU1481599808.USD","LU0882574055.USD","LU0965508806.USD","LU1670710661.SGD","LU0070302665.USD","BK4533","LU1162221912.USD","BK5011","IE0002270589.USD","LU2087621335.USD","LU0203345920.USD","LU0238689110.USD","LU2023250843.SGD","SG9999015978.USD","LU2089984988.USD","SG9999001176.USD","LU0106261372.USD","LU1430594728.SGD","SG9999014575.USD","LU0320765489.SGD","LU0306807586.USD","LU0114720955.EUR","BK4568","IE00B19Z3B42.SGD","LU0203347892.USD","LU0985320562.USD","LU2360032135.SGD","SG9999014559.SGD","SG9999002232.USD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","LU0265550359.USD","BK4578","SG9999014542.SGD","LU1934455194.USD","LU1032466523.USD","LU1400636574.HKD","LU1934455863.HKD","BK4585","IE0002141913.USD","LU2242646821.SGD","SG9999002224.SGD","LU0306806265.USD","LU0161305163.EUR","IE00B3T34201.USD","LU1015430645.USD","LU1035777561.USD","LU1046248800.SGD","BK4139","IE00BZ1G4Q59.USD","LU1989771016.USD","LU0109394709.USD","LU1291159041.SGD","LU1929549753.HKD","LU1670710588.SGD","LU0321505439.SGD","LU0545562505.USD","LU1066051811.HKD","LU1778281490.HKD","LU1309081286.SGD","LU1868836757.USD","LU2461242641.AUD","LU1064927863.SGD","LU2242652126.USD","LU1868836591.USD","IE00B7SZLL34.SGD","IE00BFTCPJ56.SGD","LU0575583348.USD","LU1670711123.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","SG9999015945.SGD","IE00BFXG1179.USD","SG9999001176.SGD","LU1400636491.USD","LU2023250504.SGD","SG9999015341.SGD","BMY","SG9999001440.SGD","BK4532","LU0061475181.USD","LU1487256676.USD","IE0009355771.USD","IE000M9KFDE8.USD","LU1037948897.HKD","LU0985481810.HKD","LU1061106388.HKD","LU1400636657.SGD","LU1699723380.USD","LU2468319806.SGD","LU1868837136.USD","LU1323610961.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU2361044949.HKD","LU1037948541.HKD","LU0130517989.USD","LU1585245621.USD","LU1093756168.USD","IE00BN8TJ469.HKD","LU0889565916.HKD","BK4516","LU0096364046.USD","IE00BKVL7J92.USD","LU0225284248.USD","LU1989772840.SGD","SG9999014567.USD","LU1228905540.USD","LU0208291251.USD","LU0265550946.USD","LU1989772923.USD","LU0320765646.SGD","LU1093756325.SGD","LU1066051225.USD","LU0320765992.SGD","IE00B2B36J28.USD","LU1069347547.HKD","BK4599","LU1917777945.USD","SG9999015986.USD","IE00BLSP4239.USD","LU0267386448.USD","LU0237698245.USD","LU0823416689.USD","LU0965509283.SGD","LU0456855351.SGD","LU1116320901.HKD","LU0130102774.USD","LU0868494617.USD","IE0034235071.USD","LU1023059063.AUD","LU1066051498.USD","LU1066053197.SGD","LU1201861249.SGD","BK4566","IE00BWDBJ516.SGD","LU1674673428.USD","LU2106854487.HKD","BK4559","LU0965509010.AUD","LU2361045086.USD","LU1868837300.USD","SG9999015952.SGD","LU1098665638.USD","LU1571399168.USD","LU0006306889.USD","LU0321505868.SGD","LU1302929846.USD","LU1116320737.USD","SG9999015358.SGD","LU0861579265.USD","LU1074936037.SGD","LU0477156953.USD","LU1228905037.USD","LU0971552830.HKD","LU2125154778.USD","LU1941712264.USD","LU0289739699.SGD","LU1035773651.USD","LU0122379950.USD","LU0971552673.USD","LU0234570918.USD","BK4007","BK4588","BK4534","IE00BSNM7G36.USD","LU1057294990.SGD","LU1839511570.USD","BK4583","IE00BQJZX424.USD","LU0980610538.SGD","LU0109981661.USD","LU1868836914.USD","LU2361044865.SGD","LU0266013472.USD","LU2125154935.USD","LU1670711040.USD","LU2112291526.USD","SG9999013999.USD"],"gpt_icon":0},{"id":"1190397083","title":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1190397083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190397083?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:22","pubTimestamp":1766172127,"startTime":"0","endTime":"0","summary":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU1670711123.USD","LU0965509283.SGD","LU1674673691.USD","BK4568","LU1074936037.SGD","LU1670756490.USD","SG9999015945.SGD","LU1778281490.HKD","LU1037948897.HKD","LU0098860793.USD","LU1917777945.USD","BK4588","LU2361044949.HKD","NVS","LU1066053197.SGD","LU1868837136.USD","BK4599","LU1032466523.USD","LU1934455194.USD","LU0109394709.USD","LU1069347547.HKD","LU1989771016.USD","LU0106261372.USD","LU0965509101.SGD","IE0002270589.USD","IE00BLSP4452.SGD","LU1974910355.USD","LU0130517989.USD","LU0882574055.USD","LU1309081286.SGD","LU1670711040.USD","SG9999001176.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","SG9999014567.USD","BK4585","GILD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU2242652126.USD","SNY","LU2023250843.SGD","RHHBY","LU1162221912.USD","LU1323610961.USD","LU2112291526.USD","LU1989772840.SGD","LU2361045086.USD","LU0971552830.HKD","AMGN","LU0648001328.SGD","LU1674673428.USD","LU1228905540.USD","LU1941712264.USD","LU0985481810.HKD","LU1116320737.USD","LU2089984988.USD","BMY","LU0096364046.USD","LU1481599808.USD","GSK","LU1670710588.SGD","LU1202635105.USD","LU2125154778.USD","LU1015430645.USD","BK4532","LU0965508806.USD","LU0965509010.AUD","SG9999013999.USD","SG9999015341.SGD","BK4581","LU0225771236.USD","BK4559","BK5011","LU0058720904.USD","LU1098665638.USD","BK4578","LU0889565916.HKD","LU1983299246.USD","IE00BWDBJ516.SGD","LU0320765646.SGD","LU0006306889.USD","IE00BKVL7J92.USD","SG9999015986.USD","LU0575583348.USD","LU2023250504.SGD","LU0130102774.USD","LU0321505439.SGD","SG9999014559.SGD","LU1839511570.USD","LU2087621335.USD","LU1941712348.USD","LU0070302665.USD","LU1645745479.HKD","IE00BJT1NW94.SGD","LU1400636491.USD","LU2468319806.SGD","SG9999014542.SGD","LU1023059063.AUD","LU2324357040.USD","LU0234570918.USD","BK4550","LU0237698245.USD","IE00B1BXHZ80.USD","LU0109981661.USD","LU1093756168.USD","LU1571399168.USD","LU1066051225.USD","LU2133065610.SGD","LU0868494617.USD","LU1064927863.SGD","LU1037948541.HKD","LU1868836591.USD","LU0320765489.SGD","LU0321505868.SGD","LU1066051811.HKD","LU1699723380.USD","LU0985320562.USD","LU1035777561.USD","LU1302929846.USD","IE00BN8TJ469.HKD","LU1989772923.USD","LU1718418525.SGD","IE00BSNM7G36.USD","BK4516","LU0861579265.USD","LU1201861249.SGD","LU1868836914.USD","LU1868837300.USD","SG9999001176.USD","LU0265550359.USD","BIIB","LU0477156953.USD","LU1228905037.USD","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU0266013472.USD","LU2242646821.SGD","LU2360032135.SGD","LU1061106388.HKD","LU1487256676.USD","LU2461242641.AUD","LU1046248800.SGD","IE00BLSP4239.USD","LU0306806265.USD","BK4583","LU0267386448.USD","IE000M9KFDE8.USD","LU0306807586.USD","BK4566","04332","LU0161305163.EUR","LU1066051498.USD","IE0009355771.USD","LU0203347892.USD","LU0320765992.SGD","SG9999015952.SGD","IE0034235071.USD","IE00B7SZLL34.SGD","LU1481600234.SGD","LU1116320901.HKD","LU2125154935.USD","LU0208291251.USD","BK4007","SG9999002232.USD","MRK","LU1291159041.SGD","BK4534","LU0061475181.USD","BK4533","SG9999002224.SGD","IE00B19Z3B42.SGD","LU1400636657.SGD","LU0211331839.USD","IE00BQJZX424.USD","LU0545562505.USD","LU0122379950.USD","LU0289739699.SGD","SG9999015978.USD","LU1670710661.SGD","LU1430594728.SGD","LU1929549753.HKD","LU0238689110.USD","LU1093756325.SGD","IE00B3T34201.USD","SGXZ57979304.SGD","LU0203345920.USD","LU1934455277.USD","LU0265550946.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU0980610538.SGD","LU1261432733.SGD","LU0456855351.SGD","LU2106854487.HKD","SG9999015358.SGD","LU0225284248.USD","LU0234572021.USD","LU1035773651.USD","LU2361044865.SGD","BK4139","LU1400636574.HKD","LU0971552673.USD","SG9999001440.SGD","SG9999014575.USD","IE00BFXG1179.USD","LU1934455863.HKD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU1585245621.USD"],"gpt_icon":0},{"id":"1185501574","title":"公司将通过Trumprx网站以更低价格直接向消费者提供多种药物-美国官员","url":"https://stock-news.laohu8.com/highlight/detail?id=1185501574","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185501574?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:21","pubTimestamp":1766172084,"startTime":"0","endTime":"0","summary":"公司将通过Trumprx网站以更低的价格向消费者直接提供多种药物-美国官员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","LU1983299246.USD","LU0456855351.SGD","LU1093756168.USD","LU0971552673.USD","LU0265550359.USD","LU0098860793.USD","04332","IE00BN8TJ469.HKD","LU0823416689.USD","LU1202635105.USD","MRK","BMY","LU1066053197.SGD","BK4599","LU0882574055.USD","LU0889565916.HKD","LU0058720904.USD","LU1989772840.SGD","LU1116320737.USD","LU0211331839.USD","LU0575583348.USD","LU1309081286.SGD","LU1487256676.USD","LU0861579265.USD","LU0225771236.USD","LU1228905037.USD","IE0034235071.USD","BK4585","BK4516","LU1481600234.SGD","LU0096364046.USD","LU0208291251.USD","SG9999001176.SGD","BK4533","LU1674673691.USD","LU0320765646.SGD","BK4532","IE00B2B36J28.USD","LU0070302665.USD","LU1066051811.HKD","LU1670756490.USD","IE00BJJMRZ35.SGD","LU0306806265.USD","LU1323610961.USD","LU1699723380.USD","LU1917777945.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","SG9999014542.SGD","LU0965509101.SGD","IE00BQJZX424.USD","GILD","LU0109981661.USD","BK4550","IE0002141913.USD","LU1778281490.HKD","LU1868836914.USD","LU0267386448.USD","LU1061106388.HKD","LU1571399168.USD","LU0114720955.EUR","BK4139","LU1057294990.SGD","IE00BFXG1179.USD","IE00BLSP4239.USD","LU1481599808.USD","LU2361044865.SGD","LU2023250843.SGD","IE00B19Z3B42.SGD","LU2112291526.USD","BK4007","LU1974910355.USD","LU1400636574.HKD","LU1162221912.USD","IE00BZ1G4Q59.USD","LU2461242641.AUD","SG9999002232.USD","LU1839511570.USD","LU0237698245.USD","LU1929549753.HKD","BK4566","LU2361044949.HKD","SG9999002224.SGD","LU1015430645.USD","LU0965508806.USD","LU0130517989.USD","LU1037948897.HKD","LU1718418525.SGD","LU1585245621.USD","LU2133065610.SGD","LU0203345920.USD","SG9999015986.USD","LU1023059063.AUD","IE00BSNM7G36.USD","LU1941712348.USD","LU0289739699.SGD","LU1400636491.USD","LU1674673428.USD","LU1201861249.SGD","LU2023250504.SGD","LU1074936037.SGD","LU0122379950.USD","LU1032466523.USD","SG9999015358.SGD","SG9999015978.USD","LU1989772923.USD","LU0130102774.USD","LU0266013472.USD","LU0238689110.USD","LU2087621335.USD","IE00B3T34201.USD","LU1228905540.USD","LU2360032135.SGD","TRUMP","LU0868494617.USD","BK4578","LU1066051225.USD","LU1037948541.HKD","LU2125154778.USD","IE00BBT3K403.USD","LU0109394709.USD","LU1046248800.SGD","LU1400636657.SGD","LU0985320562.USD","LU1291159041.SGD","LU0648001328.SGD","LU0965509010.AUD","LU1670710661.SGD","LU1989771016.USD","LU0985481810.HKD","LU1645745479.HKD","IE00BJT1NW94.SGD","LU1868836591.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","GSK","SG9999014567.USD","LU2242652126.USD","LU1670711123.USD","SG9999015341.SGD","LU1069347547.HKD","LU2125154935.USD","LU1302929846.USD","IE00B4R5TH58.HKD","LU0234572021.USD","IE0009355771.USD","IE00BWDBJ516.SGD","LU1868837300.USD","LU1035773651.USD","LU2361045086.USD","IE00BKVL7J92.USD","LU1934455863.HKD","LU2468319806.SGD","BK4534","LU0321505439.SGD","LU1670711040.USD","LU0320765992.SGD","AMGN","LU0203347892.USD","LU1116320901.HKD","LU0306807586.USD","LU0006306889.USD","BK4559","LU0234570918.USD","LU1868837136.USD","SG9999014559.SGD","LU1098665638.USD","LU1430594728.SGD","LU1064927863.SGD","LU1261432733.SGD","LU1093756325.SGD","LU0321505868.SGD","LU1868836757.USD","LU0106261372.USD","LU0971552830.HKD","IE00BLSP4452.SGD","LU2242646821.SGD","SG9999015945.SGD","LU0965509283.SGD","BK4588","SG9999015952.SGD","LU0980610538.SGD","LU0061475181.USD","IE00B7SZLL34.SGD","SG9999001176.USD","SG9999013999.USD","SGXZ57979304.SGD","LU1934455194.USD","LU0265550946.USD","BK5011","LU0225284248.USD","LU1941712264.USD","SG9999014575.USD","BK4583","LU0161305163.EUR","LU0545562505.USD","LU1670710588.SGD","LU1934455277.USD","BK4581","LU0320765489.SGD","LU0477156953.USD","IE00B1BXHZ80.USD","LU2324357040.USD","IE0002270589.USD","LU1035777561.USD","BK4568","LU2106854487.HKD","LU1066051498.USD"],"gpt_icon":0},{"id":"1119342602","title":"多家制造商同意向美国战略储备捐赠活性药物成分","url":"https://stock-news.laohu8.com/highlight/detail?id=1119342602","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119342602?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:20","pubTimestamp":1766172037,"startTime":"0","endTime":"0","summary":"多家制造商同意向美国战略储备捐赠活性药物成分。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU1291159041.SGD","LU1778281490.HKD","SG9999014542.SGD","LU0575583348.USD","SG9999014567.USD","LU0114720955.EUR","LU0985481810.HKD","SG9999015952.SGD","LU0320765489.SGD","LU1645745479.HKD","MRK","BK4516","LU1098665638.USD","IE00B2B36J28.USD","LU0289739699.SGD","LU0321505868.SGD","BK4532","LU1670756490.USD","LU0208291251.USD","LU2112291526.USD","LU1066051225.USD","LU0267386448.USD","LU0161305163.EUR","GSK.UK","IE00BFTCPJ56.SGD","LU2361044949.HKD","LU0106261372.USD","BK4550","LU1037948897.HKD","LU1674673428.USD","SG9999015986.USD","LU1309081286.SGD","LU1400636574.HKD","LU2089984988.USD","LU0320765646.SGD","LU0648001328.SGD","LU1032466523.USD","SG9999015978.USD","IE00BBT3K403.USD","BK4566","LU0985320562.USD","LU0098860793.USD","LU1934455277.USD","BK4583","LU1974910355.USD","SG9999014559.SGD","LU0266013472.USD","LU1323610961.USD","LU1934455863.HKD","IE00BJJMRZ35.SGD","LU2461242641.AUD","LU0306807586.USD","LU0061475181.USD","LU1941712264.USD","BK4534","IE00BZ1G4Q59.USD","LU1868836757.USD","IE00B1BXHZ80.USD","IE00B3T34201.USD","LU1228905037.USD","LU1093756168.USD","LU1868836914.USD","LU1929549753.HKD","LU1839511570.USD","SG9999013999.USD","LU1116320737.USD","SG9999001176.SGD","LU0971552830.HKD","BK4588","LU1046248800.SGD","LU1989772840.SGD","LU2133065610.SGD","04332","LU1093756325.SGD","BMY","BK4007","LU1037948541.HKD","LU1228905540.USD","LU1201861249.SGD","LU2106854487.HKD","SGXZ57979304.SGD","LU2242646821.SGD","LU2324357040.USD","LU1934455194.USD","LU0130102774.USD","IE0002141913.USD","LU0130517989.USD","LU1487256676.USD","LU0234570918.USD","LU1983299246.USD","LU2242652126.USD","LU2087621335.USD","LU1023059063.AUD","LU1670710661.SGD","LU1064927863.SGD","LU1868837300.USD","LU0225771236.USD","IE00BQJZX424.USD","LU1400636657.SGD","LU1069347547.HKD","SG9999014575.USD","SG9999015341.SGD","BK4139","IE0002270589.USD","IE00BN8TJ469.HKD","LU0965509101.SGD","LU0306806265.USD","LU1670711123.USD","SG9999015358.SGD","LU0058720904.USD","SG9999015945.SGD","LU0965509010.AUD","IE00B19Z3581.USD","BK5011","LU0980610538.SGD","LU1481599808.USD","LU0971552673.USD","LU1074936037.SGD","LU2360032135.SGD","GILD","BK4581","LU2125154935.USD","BK4533","LU0965509283.SGD","BK4599","IE00BLSP4239.USD","SG9999002232.USD","IE00B4R5TH58.HKD","LU1400636491.USD","BK4578","IE0009355771.USD","LU1989772923.USD","LU1941712348.USD","IE00BWDBJ516.SGD","LU0122379950.USD","LU0545562505.USD","BK4568","LU1066051498.USD","LU1481600234.SGD","LU0238689110.USD","BK4585","LU1989771016.USD","LU1035773651.USD","LU1571399168.USD","IE00BKVL7J92.USD","LU1116320901.HKD","LU2023250504.SGD","SG9999001176.USD","LU0265550946.USD","LU0109981661.USD","LU1015430645.USD","LU1917777945.USD","BK4559","LU1202635105.USD","LU0203347892.USD","LU0882574055.USD","LU1066051811.HKD","LU1670710588.SGD","LU1162221912.USD","LU0211331839.USD","LU1674673691.USD","IE00BFXG1179.USD","LU0321505439.SGD","LU0477156953.USD","LU2023250843.SGD","LU2468319806.SGD","SG9999002224.SGD","LU0203345920.USD","LU0225284248.USD","LU0096364046.USD","LU1302929846.USD","LU0320765992.SGD","LU0456855351.SGD","LU1057294990.SGD","LU1670711040.USD","LU0109394709.USD","LU0237698245.USD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","AMGN","LU1261432733.SGD","IE00B7SZLL34.SGD","LU2361044865.SGD","LU0823416689.USD","IE00BLSP4452.SGD","LU0868494617.USD","LU1868836591.USD","LU0889565916.HKD","LU1061106388.HKD","LU2361045086.USD","IE00BSNM7G36.USD","LU0861579265.USD","LU1066053197.SGD","LU1035777561.USD","SG9999001440.SGD","IE000M9KFDE8.USD","LU1868837136.USD","LU0234572021.USD","LU0265550359.USD","LU1699723380.USD","LU1718418525.SGD","LU0006306889.USD","LU1430594728.SGD","IE0034235071.USD","LU2125154778.USD","LU0965508806.USD"],"gpt_icon":0},{"id":"2592396131","title":"港股异动 | 和铂医药-B(02142)早盘涨超8% 公司与百时美施贵宝签订超10亿美元BD交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2592396131","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592396131?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:29","pubTimestamp":1766111351,"startTime":"0","endTime":"0","summary":"消息面上，和铂医药发布公告称，公司与百时美施贵宝已订立多年全球战略合作及授权协议，旨在发现及开发新一代多特异性抗体。根据协议，和铂医药将获得一笔总额为0.9亿美元的首付款，若百时美施贵宝推进所有潜在项目，公司还有资格获得最高达10.35亿美元的开发及商业里程碑付款以及分级特许权使用费。据悉，和铂医药累计与MNC达成合作已达七次，对外合作总金额超100亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0306807586.USD","02142","LU1868837300.USD","LU0868494617.USD","LU0321505439.SGD","IE00B2B36J28.USD","BK4585","LU1261432733.SGD","LU1323610961.USD","LU1868836591.USD","LU0225284248.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU0321505868.SGD","LU0096364046.USD","LU0114720955.EUR","BK4532","LU0985481810.HKD","LU0882574055.USD","LU0225771236.USD","IE0002141913.USD","LU1718418525.SGD","LU1291159041.SGD","BK4581","IE00BFXG1179.USD","BK4559","LU1093756325.SGD","BK4588","LU0237698245.USD","IE00BJT1NW94.SGD","LU1868836757.USD","LU0061475181.USD","LU0267386448.USD","LU1430594728.SGD","LU1585245621.USD","LU1670710588.SGD","LU2125154935.USD","LU2242652126.USD","LU2133065610.SGD","LU2242646821.SGD","LU0306806265.USD","LU1670711040.USD","LU1074936037.SGD","IE0009355771.USD","IE00BSNM7G36.USD","LU1032466523.USD","BK4007","BMY","LU0456855351.SGD","LU2360032135.SGD"],"gpt_icon":0},{"id":"1146684068","title":"施贵宝加拿大欢迎CDA对Opdivo®与Yervoy®联合用于MSI-H/DMMR转移性结直肠癌的一线治疗的积极推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=1146684068","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146684068?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:07","pubTimestamp":1765973241,"startTime":"0","endTime":"0","summary":"施贵宝加拿大欢迎CDA对Opdivo®与Yervoy®联合用于MSI-H/DMMR转移性结直肠癌的一线治疗的积极推荐","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","LU1074936037.SGD","LU1430594728.SGD","LU1670711123.USD","BK4588","IE0002141913.USD","BK4559","LU0114720955.EUR","LU1571399168.USD","LU2125154935.USD","LU0306806265.USD","LU1989771016.USD","LU1868836914.USD","LU0225284248.USD","LU0225771236.USD","BK4581","LU1032466523.USD","LU0882574055.USD","LU0061475181.USD","LU1585245621.USD","LU1868837300.USD","LU0096364046.USD","LU2133065610.SGD","LU1093756168.USD","LU1718418525.SGD","LU2125154778.USD","BK4534","LU0306807586.USD","BK4532","LU0267386448.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1291159041.SGD","LU1868837136.USD","IE00B2B36J28.USD","LU1670711040.USD","LU0868494617.USD","LU1261432733.SGD","IE00BFXG1179.USD","IE00BFTCPJ56.SGD","LU1323610961.USD","LU0321505439.SGD","LU0985481810.HKD","LU1670710588.SGD","LU2242652126.USD","BK4007","LU1670710661.SGD","LU0237698245.USD","LU1093756325.SGD","IE0009355771.USD","IE00BSNM7G36.USD","LU0321505868.SGD","LU1868836757.USD","IE00BJJMRZ35.SGD","LU2360032135.SGD","LU2242646821.SGD","BK4585","LU1868836591.USD"],"gpt_icon":0},{"id":"2592526179","title":"港股异动 | 和铂医药-B(02142)仍跌2% 与百时美施贵宝达成全球战略合作 潜在收益超10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592526179","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592526179?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:59","pubTimestamp":1765936773,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B(02142)小幅高开后走低，一度跌超5%，现跌幅收窄。截至发稿，跌2.08%，报12.72港元，成交额3645.09万港元。消息面上，和铂医药今早宣布，与百时美施贵宝达成长期全球战略合作及许可协议，双方将共同研发新一代多特异性抗体疗法。根据协议条款，和铂医药将与百时美施贵宝合作推进及加速多特异性抗体发现项目。和铂医药将获得总计9000万美元的付款，若百时美施贵宝选择推进所有潜在项目，和铂医药还可获得高达10.35亿美元的开发及商业里程碑付款，以及基于未来产品净销售额的分级特许权使用费。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1093756168.USD","LU0321505439.SGD","LU1868837300.USD","BK1161","LU0985481810.HKD","LU1032466523.USD","LU1571399168.USD","LU1868837136.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0306806265.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1670710661.SGD","LU1670711123.USD","LU2360032135.SGD","LU2242652126.USD","02142","IE00BFXG1179.USD","LU0225284248.USD","BK4532","BK4581","LU2242646821.SGD","LU1868836591.USD","LU1670710588.SGD","LU1323610961.USD","LU1261432733.SGD","LU1868836914.USD","BK4007","BK1574","LU0306807586.USD","LU2125154778.USD","LU0321505868.SGD","IE0002141913.USD","LU0061475181.USD","LU0882574055.USD","LU1291159041.SGD","IE00BSNM7G36.USD","BK4588","BMY","BK4534","IE00B2B36J28.USD","LU0456855351.SGD","LU2125154935.USD","LU0225771236.USD","LU0114720955.EUR","LU0237698245.USD","LU1585245621.USD","LU1718418525.SGD","LU1868836757.USD"],"gpt_icon":0},{"id":"1117376540","title":"和铂医药-B与施贵宝达成全球战略合作与许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1117376540","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117376540?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:32","pubTimestamp":1765935166,"startTime":"0","endTime":"0","summary":"12月17日（路透社）- 和铂医药-B <2142.HK>::*与施贵宝达成全球战略合作与许可协议*可能将获得总额9000万美元的支付，以及最高达10.35亿美元的发展和商业里程碑*根据协议，双方将合作推进和加速多特异性抗体发现项目*","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU1670710661.SGD","LU2360032135.SGD","BK1574","LU0882574055.USD","LU0267386448.USD","LU2242652126.USD","LU1032466523.USD","LU0868494617.USD","BK1583","LU1291159041.SGD","BK4007","IE00BFXG1179.USD","IE00B2B36J28.USD","LU0321505868.SGD","LU1868836914.USD","BMY","LU1868836757.USD","LU1868837300.USD","LU1670711123.USD","LU1670711040.USD","LU1261432733.SGD","IE00BJJMRZ35.SGD","BK4588","LU0225284248.USD","LU1323610961.USD","BK4534","LU0321505439.SGD","LU1430594728.SGD","LU1585245621.USD","LU2133065610.SGD","LU2125154935.USD","02142","LU1571399168.USD","BK4532","LU1989771016.USD","LU0237698245.USD","LU0114720955.EUR","LU2125154778.USD","IE00BSNM7G36.USD","BK4585","IE00BJT1NW94.SGD","LU2242646821.SGD","LU1074936037.SGD","LU0225771236.USD","LU1718418525.SGD","LU0096364046.USD","LU0985481810.HKD","LU1670710588.SGD","LU1093756168.USD","LU1093756325.SGD","BK1161","BK4559","LU0061475181.USD","LU0306806265.USD","LU1868836591.USD","BK4581","IE0009355771.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU1868837136.USD","LU0306807586.USD"],"gpt_icon":0},{"id":"2591022536","title":"美银上调施贵宝目标价至61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591022536","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591022536?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:46","pubTimestamp":1765874784,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0306806265.USD","LU0096364046.USD","LU1868837136.USD","IE0009355771.USD","LU0985481810.HKD","LU2125154935.USD","LU0225771236.USD","LU1093756325.SGD","LU2125154778.USD","LU0321505868.SGD","BK4007","LU2242646821.SGD","LU1291159041.SGD","IE00BFXG1179.USD","IE00BJT1NW94.SGD","LU1718418525.SGD","LU1430594728.SGD","LU0267386448.USD","IE00BSNM7G36.USD","LU1670710588.SGD","LU1585245621.USD","BK4532","IE00B2B36J28.USD","LU0114720955.EUR","LU0882574055.USD","LU1868836591.USD","LU1323610961.USD","LU0868494617.USD","LU0061475181.USD","LU1868837300.USD","BMY","BK4534","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU1670710661.SGD","LU1032466523.USD","LU2242652126.USD","LU0306807586.USD","LU1074936037.SGD","LU1670711040.USD","LU1670711123.USD","IE0002141913.USD","LU2133065610.SGD","LU2360032135.SGD","LU1868836914.USD","LU1093756168.USD","LU1571399168.USD","LU1989771016.USD","LU1868836757.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"1103261588","title":"施贵宝：Bofa全球研究将评级从中性上调至买入；目标价由52美元上调至61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103261588","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103261588?lang=zh_cn&edition=full","pubTime":"2025-12-15 19:55","pubTimestamp":1765799723,"startTime":"0","endTime":"0","summary":"施贵宝：Bofa全球研究将评级从中性上调至买入；目标价由52美元上调至61美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0237698245.USD","LU1430594728.SGD","LU1868837136.USD","BK4007","LU0267386448.USD","LU2360032135.SGD","IE00BFXG1179.USD","LU0225284248.USD","LU2125154935.USD","LU0321505439.SGD","LU0456855351.SGD","IE00B2B36J28.USD","LU0985481810.HKD","LU1670710588.SGD","LU1989771016.USD","LU1670711040.USD","BMY","LU1868836591.USD","LU0114720955.EUR","LU1868837300.USD","BK4559","IE00BSNM7G36.USD","LU0306806265.USD","LU1571399168.USD","LU1032466523.USD","LU1093756168.USD","LU1670710661.SGD","LU0061475181.USD","BK4532","LU1868836757.USD","LU0306807586.USD","LU0225771236.USD","LU0868494617.USD","LU0882574055.USD","IE0002141913.USD","LU1291159041.SGD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU1670711123.USD","LU2125154778.USD","LU1868836914.USD","BK4581","LU2242646821.SGD","LU2242652126.USD","LU1261432733.SGD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU1074936037.SGD","BK4588","LU0321505868.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","BK4585","BK4534","LU1323610961.USD","LU1093756325.SGD","LU1718418525.SGD"],"gpt_icon":0},{"id":"1145596562","title":"2025年平均回报近28%！2026年《巴伦》选股：亚马逊及另外9只股值得买入","url":"https://stock-news.laohu8.com/highlight/detail?id=1145596562","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145596562?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:27","pubTimestamp":1765787221,"startTime":"0","endTime":"0","summary":"要点速览标普500指数在2025年上涨近20%，此前在2023年和2024年均录得约25%的回报。《巴伦周刊》2025年的选股（含分红）平均回报接近28%，显著跑赢标普500指数的15%。回顾：2025年是非常好的一年《巴伦周刊》在2025年挑选的10只股票整体跑赢了标普500指数。亚马逊目前股价约232美元，2025年仅上涨约6%，按2026年预期每股收益8美元计算，市盈率约29倍，相比增长更慢、却交易在38倍市盈率的沃尔玛，估值明显偏低。","market":"us","thumbnail":"https://static.tigerbbs.com/7cb476950a20a27b5d4b430bcabd040e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/7cb476950a20a27b5d4b430bcabd040e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"dc41550f5bb7b11827b30281f97c4f1b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLG","DIS","V","FLUT","BMY","MSGS","CMCSA","XOM","AMZN","FRFHF"],"gpt_icon":1},{"id":"2590504741","title":"产业新闻 | FDA授予百时美施贵宝PD-1疗法组合优先审评资格；创新帕金森病免疫疗法积极试验结果公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2590504741","media":"药明康德","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590504741?lang=zh_cn&edition=full","pubTime":"2025-12-12 08:00","pubTimestamp":1765497601,"startTime":"0","endTime":"0","summary":"FDA授予百时美施贵宝PD-1疗法组合优先审评资格百时美施贵宝今日宣布，美国FDA已受理Opdivo的补充生物制品许可申请，用于与多柔比星、长春花碱和达卡巴嗪联合，治疗既往未接受治疗的III期或IV期经典型霍奇金淋巴瘤成人及儿童患者。FDA授予该申请优先审评资格，并将PDUFA日期确定为2026年4月8日。此次FDA受理及优先审评的决定，主要基于3期SWOG S1826研究的积极结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212092546a443889e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212092546a443889e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868837136.USD","LU1032466523.USD","LU0114720955.EUR","BK4585","BK4007","LU0321505439.SGD","IE00B2B36J28.USD","LU0868494617.USD","IE0002141913.USD","LU1989771016.USD","LU1868837300.USD","LU2242646821.SGD","LU1670711123.USD","LU2125154935.USD","LU2133065610.SGD","LU1169589451.USD","BMY","LU0321505868.SGD","LU2242652126.USD","BK4534","LU1868836591.USD","LU1670711040.USD","LU2360032135.SGD","IE00BFTCPJ56.SGD","LU1868836757.USD","LU0096364046.USD","PD","LU1169590202.USD","BK4581","LU1430594728.SGD","BK4023","BK4532","LU0882574055.USD","IE00BJJMRZ35.SGD","LU1571399168.USD","LU1323610961.USD","LU1670710588.SGD","LU1718418525.SGD","LU0456855351.SGD","IE0009355771.USD","LU0267386448.USD","LU0985481810.HKD","LU1291159041.SGD","BK4588","IE00BJT1NW94.SGD","LU1261432733.SGD","LU1093756325.SGD","LU1585245621.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"1172575849","title":"美国食品药品监督管理局（FDA）对施贵宝Opdivo®（Nivolumab）联合化疗治疗经典型霍奇金淋巴瘤的申请给予优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=1172575849","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172575849?lang=zh_cn&edition=full","pubTime":"2025-12-11 19:59","pubTimestamp":1765454366,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）对施贵宝Opdivo®（Nivolumab）联合化疗治疗经典型霍奇金淋巴瘤的申请给予优先审评。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1571399168.USD","BK4585","LU1989771016.USD","LU0114720955.EUR","BK4559","BMY","IE00BFTCPJ56.SGD","LU1323610961.USD","BK4007","LU0306806265.USD","LU1670711040.USD","LU0306807586.USD","LU0882574055.USD","IE00B2B36J28.USD","LU0096364046.USD","LU2125154778.USD","IE00BFXG1179.USD","LU0321505439.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","LU0321505868.SGD","LU1074936037.SGD","LU1093756168.USD","BK4532","LU1261432733.SGD","LU1670710661.SGD","LU0237698245.USD","LU1868837300.USD","LU1585245621.USD","LU2242652126.USD","IE0009355771.USD","LU2125154935.USD","LU2360032135.SGD","IE00BJT1NW94.SGD","LU0225771236.USD","LU2242646821.SGD","LU0225284248.USD","IE0002141913.USD","LU0456855351.SGD","LU0868494617.USD","LU1032466523.USD","LU0267386448.USD","LU0985481810.HKD","LU1868836914.USD","LU1670711123.USD","LU0061475181.USD","LU1868836591.USD","BK4588","BK4534","LU1868836757.USD","LU1718418525.SGD","BK4581","LU2133065610.SGD","LU1868837136.USD","LU1291159041.SGD","LU1670710588.SGD","LU1093756325.SGD"],"gpt_icon":0},{"id":"2590231598","title":"富国银行上调施贵宝目标价至55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590231598","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590231598?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:47","pubTimestamp":1765439222,"startTime":"0","endTime":"0","summary":"富国银行将施贵宝的目标价从53美元上调至55美元，维持“持有”评级。(格隆汇)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251211/31859114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BMY"],"gpt_icon":0},{"id":"1103967501","title":"Biontech与施贵宝公布Pumitamig全球二期研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1103967501","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103967501?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:18","pubTimestamp":1765282713,"startTime":"0","endTime":"0","summary":"12月9日（路透社）- BioNTech SE与施贵宝首次公布PD-L1XVEGF-A双特异性抗体Pumitamig在晚期三阴性乳腺癌中的全球二期研究数据，显示出令人鼓舞的疗效。Pumitamig联合化疗实现了61.5%的确认客观反应率、71.8%的未确认客观反应率和92.3%的疾病控制率，与PD-L1表达水平无关。这些数据与先前在中国进行的1L TNBC I期/II期临床试验中报告的数据一致，并确认了关键III期ROSETTA BREAST-01试验的剂量选择。相关数据将于2025年圣安东尼奥乳腺癌研讨会上公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU1571399168.USD","LU1323610961.USD","BK4551","LU2133065610.SGD","LU0868494617.USD","LU1670711123.USD","LU1868836591.USD","LU2125154935.USD","BK4007","LU1291159041.SGD","BK4534","LU0061475181.USD","LU0321505868.SGD","LU0985481810.HKD","BK4568","BMY","LU1074936037.SGD","LU0096364046.USD","LU2242652126.USD","LU1718418525.SGD","LU1670710588.SGD","BK4535","LU2125154778.USD","BK4588","LU1868837136.USD","IE00BSNM7G36.USD","LU1032466523.USD","LU1868836914.USD","LU1868837300.USD","BK4532","LU1430594728.SGD","LU1670710661.SGD","LU1093756325.SGD","BK4581","LU1989771016.USD","LU0225771236.USD","BK4559","LU1261432733.SGD","LU2242646821.SGD","LU0456855351.SGD","LU2360032135.SGD","BK4548","LU0225284248.USD","LU0306806265.USD","LU0882574055.USD","LU1670711040.USD","LU0321505439.SGD","BK4139","LU0267386448.USD","IE0002141913.USD","LU0306807586.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1868836757.USD","BK4585","IE0009355771.USD","BNTX","IE00BFXG1179.USD","LU0114720955.EUR","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0237698245.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"1117454392","title":"BioNTech Se：Pumitamig联合化疗在所有四种化疗方案中的安全性均可控","url":"https://stock-news.laohu8.com/highlight/detail?id=1117454392","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117454392?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:04","pubTimestamp":1765281849,"startTime":"0","endTime":"0","summary":"BioNTech Se：Pumitamig联合化疗在所有四种化疗方案中均展现出可管理的安全性特征，且在两个队列中均表现良好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1868837300.USD","LU0868494617.USD","LU0321505439.SGD","IE00B2B36J28.USD","BK4585","LU1261432733.SGD","LU1323610961.USD","LU1868836591.USD","LU2125154778.USD","LU0225284248.USD","LU1093756168.USD","LU1670711123.USD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0321505868.SGD","LU0096364046.USD","LU1868836914.USD","LU0114720955.EUR","BK4532","LU0985481810.HKD","LU0882574055.USD","LU0225771236.USD","IE0002141913.USD","LU1571399168.USD","LU1718418525.SGD","LU1291159041.SGD","BK4581","IE00BFXG1179.USD","BK4559","LU1093756325.SGD","BK4588","LU0237698245.USD","IE00BJT1NW94.SGD","LU1868836757.USD","LU0061475181.USD","LU0267386448.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU1585245621.USD","LU1670710661.SGD","LU1670710588.SGD","LU2125154935.USD","LU2242652126.USD","LU2133065610.SGD","LU2242646821.SGD","LU0306806265.USD","LU1670711040.USD","LU1074936037.SGD","LU1868837136.USD","IE0009355771.USD","IE00BSNM7G36.USD","LU1032466523.USD","BK4007","BMY","LU0456855351.SGD","BK4534","LU2360032135.SGD"],"gpt_icon":0},{"id":"2588040563","title":"美股异动 | 百时美施贵宝(BMY.US)涨5% 公司将继续阿尔茨海默病研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2588040563","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588040563?lang=zh_cn&edition=full","pubTime":"2025-12-03 23:30","pubTimestamp":1764775808,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，百时美施贵宝(BMY.US)涨5%，报50.67美元。消息面上，施贵宝周三表示，将招募更多参与者参加一项晚期试验，以评估Cobenfy治疗阿尔茨海默病痴呆相关精神病的安全性和有效性。该公司表示，在发现少数试验地点与临床研究执行相关的“不规范行为”后作出此决定，这些地点的患者数据将从主要分析中排除。据了解，Cobenfy目前已获批用于治疗成人精神分裂症，具有成为首个基于毒蕈碱受体激动作用、针对躁动和精神病的新一类药物疗法的潜力。预计ADEPT计划(包括ADEPT-2、ADEPT-1和ADEPT-4)针对阿尔茨海默病相关精神病的其他试验结果将在2026年底揭晓。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BJT1NW94.SGD","LU0267386448.USD","LU0321505868.SGD","LU1868836914.USD","IE0009355771.USD","BK4588","LU1261432733.SGD","LU0225284248.USD","LU1571399168.USD","LU1670710661.SGD","BK4532","LU1585245621.USD","LU0306806265.USD","LU1868836591.USD","IE0002141913.USD","LU0985481810.HKD","LU0061475181.USD","LU1093756168.USD","BK4534","LU2242646821.SGD","LU2133065610.SGD","LU1670711040.USD","BMY","LU1074936037.SGD","LU1291159041.SGD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU0114720955.EUR","LU1323610961.USD","LU2360032135.SGD","BK4559","LU0456855351.SGD","LU0225771236.USD","LU1989771016.USD","LU0321505439.SGD","BK4585","IE00B2B36J28.USD","LU1868836757.USD","LU1868837136.USD","LU1718418525.SGD","IE00BFXG1179.USD","BK4581","LU0096364046.USD","LU1430594728.SGD","LU2125154935.USD","LU0868494617.USD","IE00BSNM7G36.USD","LU1093756325.SGD","LU1670710588.SGD"],"gpt_icon":0},{"id":"1145973221","title":"施贵宝股价在盘前上涨3.4%，继续招募阿尔茨海默病药物试验患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1145973221","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145973221?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:26","pubTimestamp":1764768379,"startTime":"0","endTime":"0","summary":"施贵宝股价在盘前上涨3.4%，继续招募阿尔茨海默病药物试验患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836914.USD","LU0096364046.USD","LU1868836591.USD","LU0061475181.USD","LU0985481810.HKD","LU1989771016.USD","LU1571399168.USD","LU2242652126.USD","LU0456855351.SGD","LU2242646821.SGD","LU1670711040.USD","LU2360032135.SGD","LU0868494617.USD","LU0225284248.USD","LU1093756325.SGD","LU0306806265.USD","IE00BSNM7G36.USD","BMY","LU0882574055.USD","BK4007","BK4534","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0321505439.SGD","LU0237698245.USD","BK4532","LU1670711123.USD","LU1868837300.USD","LU1430594728.SGD","LU1032466523.USD","LU1670710588.SGD","LU2125154935.USD","BK4585","LU1670710661.SGD","LU1868837136.USD","LU1868836757.USD","LU0225771236.USD","LU0306807586.USD","LU1323610961.USD","IE00BFXG1179.USD","IE00BFTCPJ56.SGD","LU0267386448.USD","BK4588","LU0114720955.EUR","LU1074936037.SGD","LU1261432733.SGD","LU0321505868.SGD","IE00BJJMRZ35.SGD","LU1718418525.SGD","IE0002141913.USD","BK4559","LU1291159041.SGD","BK4581","LU1093756168.USD","LU2133065610.SGD","LU2125154778.USD","LU1585245621.USD","IE0009355771.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":0.1818},{"period":"3month","weight":0.2171},{"period":"6month","weight":0.171},{"period":"1year","weight":-0.0466},{"period":"ytd","weight":-0.0336}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月根据特拉华州法律注册成立，名为百时美公司，继承了1887年在纽约成立的一家企业。1989年，由于合并，公司更名为百时美施贵宝公司。该公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。该公司预计，对Celgene和MyoKardia的收购将进一步将公司定位为领先的生物制药公司，通过几项近期资产和额外的外部合作伙伴关系扩大其肿瘤学、血液学、免疫学和心血管领域的投资组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":-0.012031},{"month":2,"riseRate":0.555556,"avgChangeRate":0.009164},{"month":3,"riseRate":0.644444,"avgChangeRate":0.008753},{"month":4,"riseRate":0.478261,"avgChangeRate":-0.005913},{"month":5,"riseRate":0.565217,"avgChangeRate":0.002647},{"month":6,"riseRate":0.608696,"avgChangeRate":0.009417},{"month":7,"riseRate":0.413043,"avgChangeRate":-0.001733},{"month":8,"riseRate":0.521739,"avgChangeRate":-0.001022},{"month":9,"riseRate":0.521739,"avgChangeRate":0.00993},{"month":10,"riseRate":0.586957,"avgChangeRate":0.025121},{"month":11,"riseRate":0.630435,"avgChangeRate":0.022318},{"month":12,"riseRate":0.630435,"avgChangeRate":0.022583}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}